| pubmed-article:15172648 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0085298 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0002598 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0679699 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0162589 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:15172648 | lifeskim:mentions | umls-concept:C1880496 | lld:lifeskim |
| pubmed-article:15172648 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15172648 | pubmed:dateCreated | 2004-6-2 | lld:pubmed |
| pubmed-article:15172648 | pubmed:abstractText | MAVERIC was a randomised clinical trial designed to test the possibility of prospectively identifying patients who would benefit most from the implantable cardioverter-defibrillator (ICD) by electrophysiology (EP) study in the context of secondary prevention of sudden cardiac death (SCD) through comparing EP-guided interventions (anti-arrhythmic drugs, coronary revascularization, and ICD) against empirical amiodarone therapy. | lld:pubmed |
| pubmed-article:15172648 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15172648 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15172648 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15172648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15172648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15172648 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15172648 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15172648 | pubmed:issn | 1099-5129 | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:CooperJJ | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:GrayR GRG | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:GriffithM JMJ | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:GarrattC JCJ | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:SkehanJ DJD | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:StaffordP JPJ | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:FoschiA EAE | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:LauE WEW | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:MarshallH JHJ | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:NiG CGC | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:PathmanathanR... | lld:pubmed |
| pubmed-article:15172648 | pubmed:author | pubmed-author:CluneM MMM | lld:pubmed |
| pubmed-article:15172648 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15172648 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:15172648 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15172648 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15172648 | pubmed:pagination | 257-66 | lld:pubmed |
| pubmed-article:15172648 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:meshHeading | pubmed-meshheading:15172648... | lld:pubmed |
| pubmed-article:15172648 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15172648 | pubmed:articleTitle | The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. | lld:pubmed |
| pubmed-article:15172648 | pubmed:affiliation | Queen Elizabeth Hospital, Birmingham B15 2TH, UK. | lld:pubmed |
| pubmed-article:15172648 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15172648 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15172648 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15172648 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15172648 | pubmed:publicationType | Multicenter Study | lld:pubmed |
